Catherine Pillet

Grenoble, 38000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Using 3D Invasion properties of RCC Cell Lines In Vitro to predict their Metastatic Potential In Vivo.

Using 3D Invasion properties of RCC Cell Lines In Vitro to predict their Metastatic Potential In Vivo.

Journal: Cell death discovery

Published: November 06, 2025

Cancer selective cell death induction by a bivalent CK2 inhibitor targeting the ATP site and the allosteric αD pocket.

Cancer selective cell death induction by a bivalent CK2 inhibitor targeting the ATP site and the allosteric αD pocket.

Journal: iScience

Published: April 19, 2023

A new scaffold-free tumoroid model provides a robust preclinical tool to investigate invasion and drug response in Renal Cell Carcinoma.

A new scaffold-free tumoroid model provides a robust preclinical tool to investigate invasion and drug response in Renal Cell Carcinoma.

Journal: Cell death & disease

Published: April 12, 2023

Cooperative Blockade of CK2 and ATM Kinases Drives Apoptosis in VHL-Deficient Renal Carcinoma Cells through ROS Overproduction.

Cooperative Blockade of CK2 and ATM Kinases Drives Apoptosis in VHL-Deficient Renal Carcinoma Cells through ROS Overproduction.

Journal: Cancers

Published: January 14, 2021

A Nucleolar Isoform of the Drosophila Ubiquitin Specific Protease dUSP36 Regulates MYC-Dependent Cell Growth.

A Nucleolar Isoform of the Drosophila Ubiquitin Specific Protease dUSP36 Regulates MYC-Dependent Cell Growth.

Journal: Frontiers in cell and developmental biology

Published: February 11, 2020

Ex-Vivo Treatment of Tumor Tissue Slices as a Predictive Preclinical Method to Evaluate Targeted Therapies for Patients with Renal Carcinoma.

Ex-Vivo Treatment of Tumor Tissue Slices as a Predictive Preclinical Method to Evaluate Targeted Therapies for Patients with Renal Carcinoma.

Journal: Cancers

Published: November 30, 2019

Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma.

Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma.

Journal: Oncotarget

Published: January 26, 2018

Novel synthetic pharmacophores inducing a stabilization of cellular microtubules.

Novel synthetic pharmacophores inducing a stabilization of cellular microtubules.

Journal: Current cancer drug targets

Published: July 11, 2014

Pharmacological inhibition of LIM kinase stabilizes microtubules and inhibits neoplastic growth.

Pharmacological inhibition of LIM kinase stabilizes microtubules and inhibits neoplastic growth.

Journal: Cancer research

Published: July 05, 2012

Azaindole derivatives are inhibitors of microtubule dynamics, with anti-cancer and anti-angiogenic activities.

Azaindole derivatives are inhibitors of microtubule dynamics, with anti-cancer and anti-angiogenic activities.

Journal: British journal of pharmacology

Published: April 11, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026